MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$137,707K
EPS
-$2.52
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development-Related Party
18,672
Research and development-Nonrelated Party
106,424
General and administrative
30,508
Total operating expenses
155,604
Loss from operations
-155,604
Interest income
17,871
Total other income, net
17,871
Net loss before income taxes
-137,733
Income tax expense
217
Net loss
-137,950
Unrealized gain on marketable securities, net of tax
243
Total other comprehensive income
243
Total comprehensive loss
-137,707
Basic EPS
-2.52
Diluted EPS
-2.52
Basic Average Shares
54,676,896,000
Diluted Average Shares
54,676,896,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Unrealized gain onmarketable securities, net...$243K Total comprehensiveloss-$137,707K Total othercomprehensive income$243K Net loss-$137,950K Interest income$17,871K Net loss beforeincome taxes-$137,733K Income tax expense$217K Total other income,net$17,871K Loss from operations-$155,604K Total operatingexpenses$155,604K Research anddevelopment-Nonrelated Party$106,424K General andadministrative$30,508K Research anddevelopment-Related Party$18,672K

Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Inc. (BCAX)